Podcast
This podcast is brought to you by:
Jill Quigley, COO of Passage Bio, who was employee No. 1, discusses the company’s evolution as a genetic medicines company developing transformative therapies for the treatment of rare monogenic central nervous system disorders, and leadership lessons learned along the way.
